Experts in psychiatry and psychology have long believed that our personalities are essentially set from early childhood and remain consistent throughout life. However, new compelling evidence indicates that we can change our personalities - either on our own, with the help of a therapist, or a combination of the two - and meaningful personality change can be achieved as quickly as 30 days. The ability of someone to change their personality can have an impact on their lives. Numerous studies indicate that personality traits influence our relationships, career success, health outcomes, and even life expectancy. This presentation will review scientific evidence and practical strategies on how personality can change and impact outcomes.
This talk will cover the assessment and treatment of anxiety disorders in a primary care setting, incorporating new diagnostic issues as a result of D5M-5.
Recognize the complexities of managing patients with chronic disease and accompanying depression and/or anxiety.
In this Clinical Coffee Break, Dr. Petrini focuses on specific elements of caring for patients with personality disorders. This activity will provide a practical approach to establishing a contract with the patient as well as an overview of available drug options for patients with personality disorders.
In this talk, participants will receive an overview of the various medications that can be used to treat mental distress. The speaker will review the history of psychopharmacology, beginning with the use of anxiety medications, then hypnotics. A history of antidepressants, mood stabilizers, and antipsychotics will follow, and the speaker will end with a brief discussion of stimulants.
In this informative session, the speaker will help clinicians build better understandings with their patients and discuss how to make the office a more welcoming environment. Participants will walk away with culturally-informed and -sensitive approaches to counseling and an enhanced comprehension of the unique mental health problems faced by the LGBTQ population.
Discuss best practices to tackle opioid abuse and other pharmacological abuse in your practice. Learn about the latest guidelines and recommendations on screening, responsible prescription and disposal of opioids.
Depression is a common but complex condition, requiring accurate diagnosis, and targeted stepwise pharmacologic and nonpharmacologic interventions. In this session, learn the DSM-5 diagnostic criteria for major depression, and how changes in DSM-5 affect the diagnosis and characterization of depressive disorders; how to apply simple, quick tools to screen for depression; and how to compare and contrast treatment modalities, including pharmacotherapy and cognitive behavioral therapy (CBT).
We tend to think of advances in medicine as a new drug, laser, or surgical procedure, something high-tech and expensive. This presentation will discuss the power of comprehensive lifestyle changes, reviewing more than 30 years of research using high-tech, state-of-the-art measures to prove the power of low-tech, low-cost, and often ancient interventions. Also, the lecture will describe proven strategies for motivating people to make and maintain comprehensive lifestyle changes as well as how to personalize a way of eating and living based on an individual’s needs, genes, and preferences. Finally, the presentation will describe many of the health policy implications of comprehensive lifestyle changes as both medically effective and cost effective.
Personality Disorders can be disabling, life threatening illnesses, but even milder forms can interfere with therapeutic alliance, adherence, and treatment success in a general medical practice. In this talk, Mark Petrini, Assistant Clinical Professor of Medicine and Psychiatry at Columbia University Medical Center, provides clinicians with a systematic approach to diagnosis and management of personality disorders in practice and offers strategies for containing affect and behavioral dysregulation.
This lecture will provide an overview of recent developments in the treatment of major depressive disorder. The lecture will summarize current antidepressant medication options, and discuss augmentation strategies for patients with difficult-to-treat depression. Safety and efficacy information will be reviewed for several of the new FDA-approved medications for major depressive disorder.